# Celldex Therapeutics, Inc.: Form 8-K, filed Jun 6, 2025

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 08:05 ET
- Period: 2025-06-05
- Accession: 0001104659-25-057066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465925057066/tm2517205d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465925057066/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465925057066/tm2517205d1_8k.htm

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-057066. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.